Product
Cycloserine
Name
Cycloserine
INN Name
CYCLOSERINE
FDA Approved
Yes
3 clinical trials
2 organizations
4 indications
2 documents
Indication
Motor ActivityIndication
Multidrug-resistant tuberculosisIndication
TuberculosisIndication
Rifampicin-resistant TuberculosisClinical trial
Motor Plasticity Enhancement of Spaced iTBS Trains: a Randomized, Placebo-controlled, Crossover Trial of D-cycloserine.Status: Completed, Estimated PCD: 2021-10-06
Clinical trial
Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T) (TB-TRUST)-PLUSStatus: Active (not recruiting), Estimated PCD: 2023-04-30
Clinical trial
A Multicenter, Randomized, Open-Label Study To Evaluate The Efficacy And Safety Of A Contezolid, Delamanid and Bedaquiline-Containing Short Regimen For The Treatment Of Rifampicin-Resistant Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2026-10-01
Document
DailyMed Label: CycloserineOrganization
Parsolex Gmp Center, Inc.Document
DailyMed Label: SEROMYCINOrganization
Dr. Reddy’s Laboratories, Inc.